32.93
+0.40
+(1.23%)
As of 2:07:43 PM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 11 | 11 | 11 |
Avg. Estimate | 0.74 | 0.72 | 3.18 | 3.66 |
Low Estimate | 0.71 | 0.58 | 3.15 | 3.48 |
High Estimate | 0.78 | 0.8 | 3.24 | 3.87 |
Year Ago EPS | 0.5 | 0.62 | 2.84 | 3.18 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 10 | 11 | 11 |
Avg. Estimate | 558.9M | 548.02M | 2.21B | 2.35B |
Low Estimate | 556.3M | 542M | 2.2B | 2.33B |
High Estimate | 563.15M | 562.8M | 2.25B | 2.38B |
Year Ago Sales | 516.27M | 525.16M | 2.11B | 2.21B |
Sales Growth (year/est) | 8.26% | 4.35% | 5.02% | 6.37% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 0.48 | 0.59 | 0.61 | 0.92 |
EPS Actual | 0.5 | 0.62 | 0.73 | 0.98 |
Difference | 0.02 | 0.03 | 0.12 | 0.06 |
Surprise % | 3.42% | 4.54% | 18.89% | 7.02% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.74 | 0.72 | 3.18 | 3.66 |
7 Days Ago | 0.72 | 0.72 | 3.17 | 3.63 |
30 Days Ago | 0.72 | 0.72 | 3.17 | 3.63 |
60 Days Ago | 0.66 | 0.73 | 3.16 | 3.67 |
90 Days Ago | 0.66 | 0.73 | 3.16 | 3.67 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 7 | 1 | 1 | 2 |
Up Last 30 Days | 7 | 1 | 6 | 2 |
Down Last 7 Days | -- | 6 | -- | 5 |
Down Last 30 Days | -- | 6 | 3 | 5 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ENOV | 48.76% | 15.74% | 12.13% | 14.82% |
S&P 500 | 6.56% | 6.52% | 9.72% | 14.29% |
Upgrades & Downgrades
Reiterates | Needham: Buy to Buy | 4/2/2025 |
Maintains | Needham: Buy to Buy | 2/27/2025 |
Reiterates | Needham: Buy to Buy | 11/7/2024 |
Initiated | JMP Securities: Market Outperform | 10/3/2024 |
Maintains | Evercore ISI Group: Outperform to Outperform | 10/1/2024 |
Maintains | JP Morgan: Neutral to Neutral | 8/8/2024 |
Related Tickers
LIVN LivaNova PLC
35.95
+0.01%
ZIMV ZimVie Inc.
9.35
-1.27%
INSP Inspire Medical Systems, Inc.
152.60
+7.52%
NPCE NeuroPace, Inc.
12.46
+1.88%
CNMD CONMED Corporation
56.88
+1.14%
OFIX Orthofix Medical Inc.
14.39
-1.30%
AORT Artivion, Inc.
23.18
-0.17%
IEX IDEX Corporation
163.49
+0.62%
6954.T Fanuc Corporation
3,152.00
-11.96%
MOVE.SW Medacta Group SA
109.80
-3.51%